Trial
NCT02390284
Stop Retinal Ganglion Cell Dysfunction Study
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Miami
Collaborators
National Eye Institute (NEI)
Condition
Glaucoma
Intervention
Latanoprost
Why stopped
No patients had abnormal PERG and could not be included in the first two arms from the baseline timepoint.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-26